Georgios Chatzikonstantinou
Papers
3
Total Citations
24
H-Index
2
About
Georgios Chatzikonstantinou is a radiation oncologist whose research focuses on advancing stereotactic body radiotherapy (SBRT) and stereotactic radiosurgery for both prostate cancer and brain metastases. His most impactful work includes a real-world dosimetric comparison between CyberKnife SBRT and HDR brachytherapy for prostate cancer, a study that has garnered 16 citations and provides critical insights into treatment planning and dose delivery. He also contributed to the landmark German HYPOSTAT trial (ARO 2013-06; NCT02635256), the first prospective multicenter phase II study evaluating hypofractionated robotic SBRT for localized prostate cancer, with final results published in 2023. Additionally, Chatzikonstantinou has explored fractionated stereotactic radiotherapy as a primary or salvage treatment for large brainstem metastases, addressing a challenging clinical scenario with limited treatment options. His work demonstrates a commitment to improving precision radiotherapy techniques and expanding evidence-based applications for robotic radiosurgery systems. Through these contributions, he has helped shape modern approaches to non-invasive cancer treatment, particularly in dose escalation and hypofractionation protocols.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3